Medical News

RSS

Triglyceride-lowering drug olezarsen fails to reduce arterial plaque

Despite experiencing significant reductions in triglycerides, patients with triglycerides over 150 mg/dL and a high risk of atherosclerosis did not experience any significant change in the amount of non-calcified plaque in their coronary arteries after taking the triglyceride-lowering drug olezarsen, in a one-year sub-study presented at the American College of Cardiology's Annual Scientific Session.

30 Mar 2026

Culturally tailored food programs significantly lower blood pressure in minority adults

Black and Hispanic adults with high blood pressure (hypertension) who received a culturally tailored food-based intervention with dietitian coaching experienced a significant drop in blood pressure compared with those who received an equivalent amount of fresh produce without additional supports, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

30 Mar 2026

Red blood cell exchange transfusion may provide benefits for patients with severe babesiosis

A new study led by investigators from Mass General Brigham and Yale School of Public Health reveals that red blood cell exchange transfusion (ET) may provide critical benefits for patients hospitalized with severe babesiosis.

30 Mar 2026

Digoxin found safe to use in young patients with rheumatic heart disease

Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with those who received a placebo, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

30 Mar 2026

Discontinuing beta-blockers after heart attack found to be safe for low-risk patients

Among stable, relatively low-risk patients who had previously suffered a heart attack, discontinuing beta-blockers after at least one year was found to be non-inferior, or comparable, to continuing beta-blockers in terms of death, another heart attack or hospitalization for heart failure, according to a study presented at the American College of Cardiology's Annual Scientific Session.

30 Mar 2026

Armed conflict in Colombia significantly impacts tuberculosis incidence and mortality rates

The prolonged armed conflict in Colombia has had a significant impact on tuberculosis (TB) incidence and mortality.

30 Mar 2026

New clinical guideline adopts holistic approach to brain and heart health

A new brain–heart clinical practice guideline takes a holistic approach, integrating neurologic and mental health evidence with guidance for cardiovascular disease as many brain and heart conditions overlap and share similar risk factors.

30 Mar 2026

Study: Autism risk genes are largely consistent across different human ancestries

A new study, co-led by researchers at the Icahn School of Medicine at Mount Sinai and published March 30 in Nature Medicine [https://doi.org/ 10.1038/s41591-026-04228-6], demonstrates that genes associated with autism risk are largely the same across people of different ancestries.

30 Mar 2026

Mount Sinai researchers identify a highly prevalent recessive neurodevelopmental disorder

Researchers at the Icahn School of Medicine at Mount Sinai in New York have identified and described a previously unknown recessive neurodevelopmental disorder (NDD) that appears to be the most prevalent ever discovered.

30 Mar 2026

Study opens the door for future treatments for Sleeping Sickness

To survive in the human bloodstream, the African trypanosome parasite wears a "cloak" made of proteins known as a variant surface glycoprotein (VSG).

30 Mar 2026

CFHR1 could be a new diagnostic marker for IgA nephropathy

Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs) in the glomerular mesangium, leading to mesangial cell proliferation, enhanced extracellular matrix production, and variable infiltration of inflammatory cells.

30 Mar 2026

Probiotic therapy may offer a simple strategy to help prevent premature births

Preterm birth is a major cause of neonatal illness and death, especially among women with a history of premature delivery.

30 Mar 2026

NOX-1 identified as key molecular target to prolong ketamine's antidepressant effects

Treatment-resistant depression affects a large proportion of people with major depressive disorder, and while ketamine offers rapid relief, its antidepressant effects fade within a few weeks.

30 Mar 2026

Benefits from food fortification, yet global nutrient gaps persist

While food fortification reduces micronutrient inadequacies, additional interventions are necessary to ensure balanced nutrition and prevent excess intake.

30 Mar 2026

Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production

Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its nanodisc panel to support screening and scale-up of G-Protein Coupled Receptors (GPCRs).

From Nuclera 30 Mar 2026

Taking a placebo knowingly still improves stress and memory

Research indicates open-label placebos can ease stress and boost memory in older adults, presenting a novel, ethical strategy for promoting healthy aging.

30 Mar 2026

She owed her insurer a nickel, so it canceled her coverage

Last summer, Lorena Alvarado Hill received a series of unexpected medical bills.

30 Mar 2026

Inside the high-stakes corporate fight over feeding preterm babies

In 2013, a scientist at Abbott Laboratories saw study results with potentially big implications for the company's profits and the lives of some of the world's most fragile people: preterm infants.

30 Mar 2026

Why attachment anxiety makes short-form video addiction more likely

Short-form video addiction is associated with attachment anxiety and attentional control, suggesting psychological factors influence digital media engagement.

30 Mar 2026

Short bursts of vigorous activity can lower risk of major diseases

People who get just a few minutes of vigorous activity daily are less likely to develop eight major diseases, including arthritis, heart disease and dementia, according to research published in the European Heart Journal today (Monday).

29 Mar 2026

Medical News

Triglyceride-lowering drug olezarsen fails to reduce arterial plaque

Culturally tailored food programs significantly lower blood pressure in minority adults

Red blood cell exchange transfusion may provide benefits for patients with severe babesiosis

Digoxin found safe to use in young patients with rheumatic heart disease

Discontinuing beta-blockers after heart attack found to be safe for low-risk patients

Armed conflict in Colombia significantly impacts tuberculosis incidence and mortality rates

New clinical guideline adopts holistic approach to brain and heart health

Study: Autism risk genes are largely consistent across different human ancestries

Mount Sinai researchers identify a highly prevalent recessive neurodevelopmental disorder

Study opens the door for future treatments for Sleeping Sickness

CFHR1 could be a new diagnostic marker for IgA nephropathy

Probiotic therapy may offer a simple strategy to help prevent premature births

NOX-1 identified as key molecular target to prolong ketamine's antidepressant effects

Benefits from food fortification, yet global nutrient gaps persist

Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production

Taking a placebo knowingly still improves stress and memory

She owed her insurer a nickel, so it canceled her coverage

Inside the high-stakes corporate fight over feeding preterm babies

Why attachment anxiety makes short-form video addiction more likely

Short bursts of vigorous activity can lower risk of major diseases

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News